aTyr Pharma Ord Shs
LIFE10.130USD
+0.030+0.30%
收盘 03/27, 16:00（美东）报价延迟15分钟
633.72M总市值
8.91市盈率 TTM
关于 aTyr Pharma Ord Shs 公司
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
aTyr Pharma Ord Shs简介
公司代码LIFE
公司名称Ethos Technologies Inc
上市日期May 07, 2015
CEOColis (Peter George)
员工数量- -
证券类型Ordinary Share
年结日May 07
公司地址1606 Headway Circle
城市AUSTIN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编78754
电话13026365400
网址https://www.ethos.com/
公司代码LIFE
上市日期May 07, 2015
CEOColis (Peter George)
aTyr Pharma Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nancy E. Denyes, J.D.
Ms. Nancy E. Denyes, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Sara A. Zaknoen, M.D.
Dr. Sara A. Zaknoen, M.D.
Independent Director
Independent Director
--
--
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Dr. Paul R. Schimmel, Ph.D.
Dr. Paul R. Schimmel, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill M. Broadfoot
Ms. Jill M. Broadfoot
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月20日 周五
更新时间: 2月20日 周五
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
其他
58.79%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
15.00%
Federated Hermes Global Investment Management Corp.
10.76%
BlackRock Institutional Trust Company, N.A.
6.10%
The Vanguard Group, Inc.
5.06%
State Street Investment Management (US)
4.28%
其他
58.79%
股东类型
持股股东
占比
Venture Capital
24.49%
Individual Investor
12.09%
Investment Advisor
10.75%
Investment Advisor/Hedge Fund
0.79%
其他
51.88%
机构持股
更新时间: 1月30日 周五
更新时间: 1月30日 周五
报告期
机构数
持股数
持股占比
持股变动
2026Q1
240
61.49M
62.75%
-12.15M
2025Q4
244
60.50M
61.75%
-16.64M
2025Q3
241
62.16M
63.44%
-11.39M
2025Q2
207
66.51M
74.72%
-166.29K
2025Q1
151
62.77M
70.80%
+2.91M
2024Q4
133
55.86M
66.65%
-3.11M
2024Q3
108
48.56M
65.39%
-7.43M
2024Q2
103
48.81M
71.98%
+527.76K
2024Q1
101
42.52M
63.83%
-4.61M
2023Q4
100
41.92M
72.67%
-1.23M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
14.70M
15%
+1.35M
+10.09%
Sep 30, 2025
Federated Hermes Global Investment Management Corp.
10.54M
10.76%
-4.12M
-28.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.98M
6.1%
+635.14K
+11.89%
Sep 30, 2025
The Vanguard Group, Inc.
4.96M
5.06%
-669.06K
-11.88%
Dec 31, 2025
State Street Investment Management (US)
4.20M
4.28%
+2.96M
+238.49%
Sep 30, 2025
GSA Capital Partners LLP
706.73K
0.72%
+210.44K
+42.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.18M
2.22%
+80.13K
+3.82%
Sep 30, 2025
Millennium Management LLC
1.89M
1.93%
+290.72K
+18.17%
Sep 30, 2025
UBS Financial Services, Inc.
4.34M
4.43%
+2.59M
+148.61%
Sep 30, 2025
Schimmel (Paul R Ph.D.)
1.10M
1.12%
+100.00K
+9.99%
Mar 01, 2025
查看更多
持股ETF
更新时间: 1月30日 周五
更新时间: 1月30日 周五
机构名称
占比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Value ETF
0%
Vanguard US Momentum Factor ETF
0%
Pacer WealthShield ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
查看更多
iShares Micro-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
Global X Russell 2000 ETF
占比0%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
Vanguard US Momentum Factor ETF
占比0%
Pacer WealthShield ETF
占比0%
Direxion Daily S&P Biotech Bull 3X Shares
占比0%
Avantis US Small Cap Equity ETF
占比0%
ProShares UltraPro Russell2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
